The results of several meta-analyses have firmly established that the apolipoprotein E (APOE) epsilon polymorphism (defined by the rs7412 and rs429358 single nucleotide polymorphisms (SNPs)) is a genetic risk factor for CHD [11-14]. This evidence concerns the gene APOE and coronary artery disorder.